ArticleInternational journal of biological sciences2024

Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer.

Min Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.